Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Novel Magnetic Nanoclusters

Abstract:
While it is not yet an imminent miracle cure for cancer, one day in the future the use of nanoparticles may herald a complete cure for some types of cancer, even those disseminated varieties that are currently difficult to treat.

Novel Magnetic Nanoclusters

August 25, 2005

A University of Leicester research project has received funding of £102,944 from the Engineering and Physical Sciences Research Council (EPSRC) to produce new types of magnetic nanoparticles for use in cancer diagnosis and cancer treatment. The project aims to solve some of the technological problems involved with using magnetic nanoparticles (particles containing just a few hundred atoms) in medical applications, including targeted drug delivery, ultra-high sensitivity detection of tumours and cancer treatments. The research project spans several departments and is being run by Dr Andrew Ellis, Department of Chemistry, Prof. Chris Binns, Department of Physics & Astronomy, and Prof. Kilian Mellon, Department of Cancer Studies and Molecular Medicine.

Prof Binns commented: “At Leicester we are building a unique source of magnetic nanoparticles in which each one has a layered structure of different materials (like a nano-onion). This means that you can design suitable magnetic properties into each nanoparticle to perform a specific task. If the particles are then coated with a final shell of gold they can be attached to biological molecules (such as drugs or antibodies) to perform the diagnosis and therapies described above.”

A novel process for making magnetic nanoparticles will be used, based on layer-by-layer synthesis of nanoparticles inside the supercold, superfluid environment of a liquid helium droplet. This will enable the design of nanoparticles with a degree of control that has hitherto not been possible. The flexibility of the synthetic scheme extends beyond magnetic nanoparticle production, allowing the systematic design of entirely new classes of nanoparticles. Nanotechnology is showing enormous promise as a provider of new tools for probing and manipulating biological systems. Particles with diameters of a few nanometres are sufficiently small that they can readily pass along narrow blood capillaries and may also pass through cell and nuclear membranes.

Prof Binns added: “The main technological problem is that the particles are formed in the gas-phase in ultra-clean vacuum conditions and we have to get them somehow from that environment into a liquid suspension in which they can be attached to biological molecules. Our project is focused on testing ways of doing this and we hope that by the end, in 18 months’ time, we will have magnetic nanoparticles with attached bio-molecules ready for testing in vitro.”

Prof Binns emphasised that this does not mean a cure for cancer within that time framework.

####
Contact:
Prof Chris Binns
Department of Physics and Astronomy
University of Leicester
tel 0116 252 3585
cb12@le.ac.uk


Copyright © University of Leicester

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Possible Futures

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Video captures bubble-blowing battery in action: Researchers propose how bubbles form, could lead to smaller lithium-air batteries April 26th, 2017

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

Investments/IPO's/Splits

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Materials/Metamaterials

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

Graphene holds up under high pressure: Used in filtration membranes, ultrathin material could help make desalination more productive April 24th, 2017

Russian scientists create new system of concrete building structures: Sientists of Peter the Great Saint-Petersburg Polytechnic University developed a new construction technology April 24th, 2017

Announcements

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project